The cranial implants market has seen considerable growth due to a variety of factors.
• In recent years, the size of the cranial implants market has experienced significant growth. The increase from $1.2 billion in 2024 to $1.33 billion in 2025 signifies a compound annual growth rate (CAGR) of 10.3%.
Factors contributing to this historic period of growth include an upsurge in trauma and injury cases, an increase in neurological surgeries and patient-specific implants, a growing aging population, regulatory compliance, and a rise in medical tourism.
The cranial implants market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for cranial implants is anticipated to witness a swift expansion in the coming years, escalating to $1.99 billion in 2029 with a Compound Annual Growth Rate (CAGAR) of 10.7%.
The surge during the prediction span is credited to the rise of emerging technologies, augmented use of minimally invasive methods, soaring instances of neurological disorders, the proliferation of telemedicine and remote surgery, and the increasing requirement for biocompatible materials. Noteworthy tendencies for the forecast span are the integration of the Internet of Things (IoT), personalized cranial reconstruction, technological advancements, ingenious resolutions, and strategic collaborations.
The escalation in neurological disease prevalence is anticipated to boost the cranial implants market growth in the imminent future. Neurological disorders encompass conditions that disrupt the functioning of the nervous system including the brain, spinal cord, and nerve networks. The heightened occurrence of these disorders could stem from a blend of causes such as genetic predisposition, infections, physical trauma, toxins, autoimmune reactions, and degeneration. Crucial to neurological surgeries, cranial implants serve a critical function by offering substantial improvements in the treatment of various disorders through supplying structural support and safeguarding delicate brain tissue following trauma or surgery. For instance, as conveyed by the European Brain Council, a non-profit entity based in Belgium, in April 2022, upwards of 600 neurological diseases along with nearly 300 psychiatric conditions affect countless individuals globally, of which 65 million are epileptic. In Europe, dementia victims reach 10.5 million, with predictions suggesting an escalation to 18.7 million before 2050 ends. As such, the surge in neurological disorder prevalence fuels the cranial implants market expansion.
The cranial implants market covered in this report is segmented –
1) By Type: Customized Cranial Implants, Non-customized Cranial Implants
2) By Material: Polymer, Ceramic, Metal
3) By End User: Hospital and Trauma Centers, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Customized Cranial Implants: 3D-Printed Customized Implants, Patient-Specific Anatomical Models, CAD/CAM Customized Implants
2) By Non-Customized Cranial Implants: Standard Cranial Plates, Pre-formed Cranial Implants, Mesh Implants
Leading companies in the cranial implants industry are adopting and creating new technologies like 3D printing to boost their market profitability. Essentially, 3D printing is a method that creates tangible objects from a digital model. Specifically, in October 2023, a well-known American 3D printer manufacturer called 3D Systems introduced 3D printing technology for cranial implants. They developed a PEEK (polyetheretherketone) implant that is engineered to match the specific anatomy of a patient. Cranial implants that are both custom-made and legally compliant can be generated using 3D printing. This personalized approach promises an enhanced fit and improved patient outcomes.
Major companies operating in the cranial implants market include:
• B. Braun Melsungen AG
• DePuy Synthes Inc.
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Kelyniam Global Inc.
• Medartis Holding AG
• Osteomed LLC
• KLS Martin Group
• Renishaw plc
• Xilloc Medical B.V.
• Medtronic plc
• Evonos GmbH
• Synimed GmbH
• Johnson & Johnson Services Ltd.
• Integra LifeSciences Corporation
• OssDsign AB
• Medicon eG
• BIOARCHITECTS
• Matrix Meditec Pvt. Ltd.
• Matrix Surgical USA
• Anatomics Pty Ltd.
• Biomet Microfixation Inc.
• Cranios USA
North America was the largest region in the cranial implants market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cranial implants market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.